| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA | /s/ Michael Simone, Attorney-in-Fact | 06 Jan 2026 | 0001544635 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BRKR | Common Stock | Options Exercise | $99,988 | +4,506 | +3.5% | $22.19 | 132,949 | 05 Jan 2026 | Direct | |
| transaction | BRKR | Common Stock | Options Exercise | $310,660 | +14,000 | +11% | $22.19 | 146,949 | 05 Jan 2026 | Direct | |
| transaction | BRKR | Common Stock | Options Exercise | $340,328 | +15,337 | +10% | $22.19 | 162,286 | 05 Jan 2026 | Direct | |
| transaction | BRKR | Common Stock | Sale | $225,300 | -4,506 | -2.8% | $50.00 | 157,780 | 05 Jan 2026 | Direct | F1 |
| transaction | BRKR | Common Stock | Sale | $700,000 | -14,000 | -8.9% | $50.00 | 143,780 | 05 Jan 2026 | Direct | F1 |
| transaction | BRKR | Common Stock | Sale | $755,347 | -15,337 | -11% | $49.25 | 128,443 | 05 Jan 2026 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BRKR | Stock Option (Right to Purchase) | Options Exercise | $0 | -4,506 | -100% | $0.000000 | 0 | 05 Jan 2026 | Common Stock | 4,506 | $22.19 | Direct | F3 |
| transaction | BRKR | Stock Option (Right to Purchase) | Options Exercise | $0 | -14,000 | -26% | $0.000000 | 40,337 | 05 Jan 2026 | Common Stock | 14,000 | $22.19 | Direct | F4 |
| transaction | BRKR | Stock Option (Right to Purchase) | Options Exercise | $0 | -15,337 | -38% | $0.000000 | 25,000 | 05 Jan 2026 | Common Stock | 15,337 | $22.19 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.74 to $50.065, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests in full on the fourth anniversary of the Original Grant Date. |
| F4 | The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. |